Eduardo Tolosa Selected Research

Eduardo Tolosa Research Topics

Disease

109	Parkinson Disease (Parkinson's Disease) 02/2024 - 03/2002
19	Dementia (Dementias) 02/2024 - 09/2002
18	Parkinsonian Disorders (Parkinsonism) 01/2021 - 04/2002
12	Dyskinesias (Dyskinesia) 10/2018 - 01/2002
8	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 09/2003
8	REM Sleep Behavior Disorder 01/2024 - 02/2015
8	Synucleinopathies 01/2023 - 09/2003
8	Alzheimer Disease (Alzheimer's Disease) 09/2012 - 12/2003
6	Multiple System Atrophy 01/2021 - 06/2007
5	Tremor (Tremors) 01/2015 - 10/2007
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2014 - 08/2002
4	Cognitive Dysfunction 01/2018 - 02/2008
4	Hypokinesia (Bradykinesia) 01/2015 - 10/2007
3	Inflammation (Inflammations) 01/2023 - 10/2020
3	Deglutition Disorders (Dysphagia) 03/2022 - 01/2018
3	Movement Disorders (Movement Disorder) 08/2014 - 06/2012
3	Atrophy 04/2014 - 12/2011
3	Tauopathies 08/2005 - 12/2003
2	Neuroinflammatory Diseases 12/2020 - 10/2017
2	Respiratory Sounds (Crackle) 10/2019 - 10/2003
2	Dystonia (Limb Dystonia) 06/2014 - 12/2006
2	Diarrhea 04/2014 - 11/2013
2	Dizziness (Lightheadedness) 11/2013 - 01/2011
2	Fatigue 11/2013 - 05/2011
2	Disease Progression 06/2010 - 09/2009
2	Disorders of Excessive Somnolence (Hypersomnia) 12/2009 - 09/2007
1	Orthostatic Hypotension (Postural Hypotension) 09/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	AIDS-Related Complex (ARC) 11/2022
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Neoplasms (Cancer) 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Paraneoplastic Cerebellar Degeneration 06/2015
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 06/2015
1	Prodromal Symptoms 05/2015

Drug/Important Bio-Agent (IBA)

34	Levodopa (L Dopa)FDA LinkGeneric 09/2023 - 01/2002
18	SynucleinsIBA 02/2024 - 09/2003
18	Phosphotransferases (Kinase)IBA 01/2023 - 04/2003
15	Leucine (L-Leucine)FDA Link 01/2023 - 06/2007
14	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2011
8	Dopamine (Intropin)FDA LinkGeneric 02/2024 - 09/2005
7	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 10/2004
5	alpha-SynucleinIBA 07/2014 - 09/2003
5	rasagiline (Azilect)FDA Link 06/2014 - 11/2008
4	Cholinergic Agents (Cholinergics)IBA 01/2024 - 09/2007
4	opicaponeIBA 01/2022 - 07/2017
4	Carbidopa (Lodosyn)FDA LinkGeneric 11/2017 - 07/2010
4	Messenger RNA (mRNA)IBA 06/2015 - 12/2002
4	ioflupaneIBA 08/2014 - 10/2004
4	entacapone (Comtan)FDA Link 04/2014 - 04/2009
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 09/2003
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2018 - 10/2009
3	rotigotine FDA Link 01/2018 - 06/2007
3	perampanelIBA 02/2012 - 05/2010
3	Pramipexole (Mirapex)FDA LinkGeneric 06/2010 - 11/2006
3	UbiquitinIBA 06/2010 - 12/2003
2	Donepezil (Aricept)FDA LinkGeneric 01/2024 - 09/2012
2	AcetylcholinesteraseIBA 01/2024 - 12/2020
2	MicroRNAs (MicroRNA)IBA 02/2023 - 05/2015
2	Mitochondrial DNA (mtDNA)IBA 11/2022 - 10/2019
2	mesoglycanIBA 03/2022 - 11/2021
2	Glucosylceramidase (Glucocerebrosidase)IBA 11/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 07/2014
2	Amyloid (Amyloid Fibrils)IBA 08/2016 - 01/2011
2	Glycogen Synthase Kinase 3IBA 04/2014 - 12/2003
2	tau Proteins (tau Protein)IBA 04/2014 - 05/2004
2	Excitatory Amino Acid AntagonistsIBA 01/2012 - 02/2004
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 12/2011 - 03/2009
2	3-Iodobenzylguanidine (Iobenguane)IBA 06/2011 - 06/2011
2	OrexinsIBA 12/2009 - 09/2007
2	Apomorphine FDA Link 06/2009 - 12/2004
2	Protein Isoforms (Isoforms)IBA 08/2005 - 08/2002
1	Interleukin-6 (Interleukin 6)IBA 02/2024
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2023
1	Coffee FDA Link 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	3-nitrotyrosineIBA 05/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020
1	catechol (pyrocatechol)IBA 10/2018
1	TransferasesIBA 10/2018
1	Dynamin IIIIBA 01/2018
1	ErgolinesIBA 01/2018
1	Cystatin CIBA 06/2015
1	CathepsinsIBA 06/2015
1	neuromelaninIBA 01/2015
1	ManganeseIBA 06/2014
1	monomethylpropion (methcathinone)IBA 06/2014

Therapy/Procedure

17	Therapeutics 01/2023 - 12/2004
6	Deep Brain Stimulation 01/2019 - 03/2002
2	Activities of Daily Living (ADL) 01/2018 - 02/2006
2	Denervation 03/2016 - 12/2011
1	Intravenous Infusions 01/2022
1	Gastrostomy 01/2021
1	Tracheostomy 10/2019
1	Continuous Positive Airway Pressure 10/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Transdermal Patch 01/2018